Revamp Medical

Developer of a catheter-based device designed to address the significant unmet clinical need in acute heart failure treatment.

Medical Devices
Active
Series A Netanya, Israel Founded 2016
Last updated 2026-08-23
Total raised
Last: Undisclosed Round 2023-05
Stage
Series A
Founded
2016
Headcount
1-10
HQ
Netanya, Israel
Sector
Medical Devices

About

Revamp Medical is a privately held clinical-stage medical technology company committed to developing solutions for Heart Failure congestion management. The company's Doraya™ device is a catheter-delivered flow modulator, placed temporarily in the inferior vena cava just below the renal veins. Doraya is designed to lower central venous pressure (CVP) and renal afterload, thereby improving renal filtration and responsiveness to diuretics, aiming to improve diuretic efficacy and progressive decongestion in acute heart failure patients.

Funding history · 2 rounds · — total

2 events/rounds · Total Funding
May 2023
A Round Undisclosed medicaldevice-network.com ↗
Jan 2019
Grant Undisclosed tracxn.com

Offices

Netanya, Israel · HQ / main office

Q&A

What is Revamp Medical's primary focus?
Revamp Medical is a clinical-stage medical technology company developing solutions for Heart Failure congestion management, specifically a catheter-based device called Doraya™.
When was Revamp Medical founded?
Revamp Medical was founded in 2016.
How many employees does Revamp Medical have?
Revamp Medical has 11-50 employees.
Which investor led Revamp Medical's Series A funding round?
KCK Medtech led Revamp Medical's Series A funding round in May 2023.
What is the total amount of funding Revamp Medical has raised?
Revamp Medical has raised a total of $111,000 USD.
What is the purpose of Revamp Medical's Doraya™ device?
The Doraya™ device is a catheter-delivered flow modulator designed to lower central venous pressure (CVP) and renal afterload, aiming to improve diuretic efficacy and progressive decongestion in acute heart failure patients.
Did Revamp Medical receive any significant regulatory designations for its product?
Yes, in July 2020, Revamp Medical's DORAYA acute heart failure catheter received FDA breakthrough device designation.
Who are the co-founders of Revamp Medical?
The co-founders of Revamp Medical are Lihu Avitov and Rafi Benary.

Team · 6

Lihu Avitov
Founder · Co-founder, Board Member
Rafi Benary
Founder · CTO, Co-founder
Mike Favet
CEO
Yael Shohat
COO
Sahar Boostenay
Clinical Director
Offer Razi
Senior Director of Operations and Engineering

Sectors & technology

Primary sector
Medical Devices
Technologies
Target customers
Business model
B2B

Highlights

1 PatentsVerified

Tags

heart-failurehealthcare-providersmedical-devicessurgerydoctorshospitalscatheterscardiologymedical-technologiestreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiterevampmedical.com
LinkedInlinkedin.com/company/12953721

Identifiers & details

Legal nameRevamp Medical Inc.
Founded2016
Employees (exact)30

Radar intelligence

Patents

EPO5

Web history (Wayback)

Domainrevampmedical.com

Certificate / subdomain footprint

Subdomains8

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515360378
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2015-12-21
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)yes
Last annual report2023
Active charges / liens0
Registry events1 — violation (1)
Registered addressמפי 5 נתניה

Recent registry events

DateEvent
2026-06-25עדכון הפרה